Kaleido BioSciences
IPO News: Filed S-1: Kaleido Biosciences Files $100mm IPO
Kaleido BioSciences

NASDAQ:  KLDO

Initial Filing Date:  01/11/19

Size:  $100mm

Bookrunners:  GS | JPM | MS

Major Holders:  Flagship Pioneering Funds | Platinum Falcon | Alison Lawton

Description: Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health

Note: Emerging Growth Company

Reference Link:  S-1